Linear IgA bullous dermatosis (LABD), also known as linear IgA dermatosis, is a rare immune-mediated disease that results in blistering of the skin, in the subepidermal layers. It is commonly ...

Background: Bullous autoimmune dermatoses are a clinically and immunopathologically heterogeneous group of diseases, characterized clinically by blisters or erosions of the skin and/or mucous ...

Bullous hemorrhagic dermatosis is an uncommon nonimmune adverse drug reaction to heparin-based anticoagulants including unfractionated heparin, low-molecular-weight heparin and fondaparinux that ...

Here, we describe a patient with non-Hodgkin's lymphoma who developed LABD after autologous HSCT and was successfully treated with glucocorticoid, dapsone and high-dose i.v. Ig, but the lymphoma ...

For centuries, bullous pemphigoid (BP) was grouped with and considered a condition similar to pemphigus vulgaris (PV). In 1953, however, Lever recognized BP as a disorder distinct from PV. 9 BP, the ...

A 55-year-old man presents to the clinic with multiple tense bullae diffusely involving his trunk and extremities that overlie urticarial plaques. The patient states that for the past 4 weeks, his ...

These skin diseases are associated with a range of debilitating symptoms that pose a significant medical burden to patients and often negatively impact their quality of life. 1-4 With these milestones ...

BP180, also known as collagen XVII, is a hemidesmosomal component and plays a key role in maintaining skin dermal/epidermal adhesion. Dysfunction of BP180, either through genetic mutations in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A 26-month-old boy presented for evaluation of acute ...

Linear IgA bullous dermatosis (LABD) is an autoimmune disease that causes blisters. People with LABD can develop blisters in the skin and the mucous membranes in their mouth, genitals, and eyelids.

Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, said: “Bullous pemphigoid, atopic dermatitis, and chronic spontaneous urticaria continue to represent a significant burden to millions ...